Option Care Health, Inc. (OPCH) Price-to-Projected Revenue Ratio

Corporate emblem and logo of Option Care Health (OPCH)

Option Care Health (OPCH) is implementing IoT monitoring and telemedicine to reduce the burden on inpatient facilities. The forward P/S ratio reflects the current market valuation, where 0.60 represents the latest level. A network of specialized pharmacies ensures the stability of medication delivery. However, labor shortages and logistics costs could constrain profits, creating certain risks for long-term capitalization growth.

OPCH Option Care: Market Cap to Projected Revenue in the range 07/04/2022 - 11/13/2026

Summary analytical data breakdowns for Option Care Corp (OPCH)

- current price and projected stock value:
Fundamental company analysis:OPCH (Option Care Health, Inc.)
Product sample of Option Care Corp

As the largest home infusion therapy operator in the US with a broad payer base, Option Care Health (OPCH) demonstrates high resilience to local regulatory risks. The ratio of current market capitalization to expected revenue allows for an assessment of market expectations for future business growth, while the company's forward P/S trend helps investors identify the cycle phase and timely align the asset's value with its fundamental prospects.

Key competitors

Forward P/S Multiple HCA (HCA Healthcare)|Market Cap to Expected Sales Ratio Tenet Healthcare Corp (THC)|FMS - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Solventum Health|Encompass Health (EHC) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue UHS|Forward Price-to-Revenue Multiple DVA|RDNT: Forward Price to Sales|Forward P/S Multiple SGRY|Forward Price-to-Revenue Multiple Premier Health PINC|Forward P/S Multiple EYE (National Vision Holdings)|Forward P/S Multiple progyny.com PGNY|ARDT - Price-to-Projected Revenue Ratio|Forward Price to Sales SEM (Select Medical Corporation)|ASTH: Forward P/S Multiple|Market Cap to Future Revenue Ratio MEDNAX (MD)|Forward Price-to-Revenue Multiple USPH|PNTG: Forward Price to Sales|Forward P/S Multiple ORGO|NUTX (Nutex Health Inc) - Forward Price to Sales|Forward P/S Multiple AUNA (Auna Health)|SBC Medical Group Holdings (SBC) - Market Cap to Future Revenue Ratio|Evolus, Inc. - Forward P/S Multiple|CYH - Forward P/S Multiple|beautyhealth.com (SKIN) - Price-to-Projected Revenue Ratio|MDWD (MediWound) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple BTMD|JYNT (The Joint) - Price to Expected Revenue Ratio|Forward P/S Multiple DCGO|PIII (p3hp.org) - Forward Price to Sales|Price-to-Projected Revenue Ratio Gain Therapeutics GANX|EUDA Health Holdings (EUDA) - Market Cap to Future Revenue Ratio|BMGL - Price-to-Projected Revenue Ratio|Future Price to Revenue CLGN|CUPR: Forward P/S Multiple|Forward Price-to-Revenue Multiple concordmedical.com|AMS (American Shared Hospital Services) - Forward P/S Multiple|MRM: Forward Price to Sales|Forward Price-to-Revenue Multiple ALBT (Avalon GloboCare)|Price to Expected Revenue Ratio DHAI|Price-to-Projected Revenue Ratio Longevity Health Holdings XAGE|Forward Price to Sales NIVF|ATI Physical Therapy Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio CareMax Inc.|KDLY: Forward P/S Multiple|ModivCare Corp (MODV) - Forward P/S Multiple|Forward Price-to-Revenue Multiple NVOS|SSY (SunLink Health Systems, Inc) - Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio IMAC Holdings (BACK)